9,10-dimethyl-1,2-benzanthracene has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amer, SA; Dakrory, AI; Fahmy, SR; Mohamed, AS; Soliman, AM | 1 |
| Ahmed, S; Jamdade, V; Kumar, P; Lahkar, M; Mundhe, NA; Mundhe, S | 1 |
| Jamdade, VS; Kumar, P; Lahkar, M; Mundhe, NA; Tadla, V | 1 |
| Gupta, J; Kumar, P; Tikoo, K | 1 |
4 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Kidney Diseases
| Article | Year |
|---|---|
Protective and curative effects of the sea cucumber Holothuria atra extract against DMBA-induced hepatorenal diseases in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Free Radical Scavengers; Free Radicals; Kidney Diseases; Male; Rats; Rats, Wistar; Reactive Oxygen Species; Sea Cucumbers; Treatment Outcome | 2015 |
Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antioxidants; Blood Urea Nitrogen; Catalase; Cisplatin; Creatinine; Female; Kidney; Kidney Diseases; Lipid Peroxidation; Mammary Neoplasms, Experimental; Masoprocol; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Burden | 2015 |
Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Cisplatin; Drug Synergism; Female; Inflammation; Kidney Diseases; Mammary Neoplasms, Animal; NF-kappa B; Raloxifene Hydrochloride; Rats; Rats, Wistar; Signal Transduction | 2016 |
Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Urea Nitrogen; Blotting, Western; Body Weight; Cisplatin; Creatinine; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Histones; Kidney; Kidney Diseases; Mammary Glands, Animal; Mammary Neoplasms, Experimental; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Serum Albumin; Thiazolidinediones; Tumor Burden; Tumor Necrosis Factor-alpha | 2009 |